Mechanism of Bradykinin-Induced Ca2+Mobilization in Murine Proximal Tubule Epithelial Cells
- 21 January 2005
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in The Journal of pharmacology and experimental therapeutics
- Vol. 313 (2), 798-805
- https://doi.org/10.1124/jpet.104.080408
Abstract
Despite the recognized physiological role of bradykinin (BK) in the kidney in maintaining glomerular and tubule function and its role in pathological states such as endotoxemia, diabetes, and other diseases, relatively little is known about the mechanisms by which BK can impact kidney function. Furthermore, the signaling of BK receptors in the murine nephron has not been fully characterized. The present studies were undertaken to examine BK-stimulated Ca2+ signaling using Fura-2 in the murine proximal tubule epithelial cell line TKPTS. BK produced a concentration-dependent rise in intracellular Ca2+ ([Ca2+])i (pEC50 = 8.39 ± 0.04). Selective antagonists showed the rise in [Ca2+]i was mediated through B2 receptors. The rise in [Ca2+]i was rapid and reversible and was maximally stimulated at 1 μM (697 ± 70 nM above basal level of 115 ± 6 nM). Studies with thapsigargin and EGTA showed Ca2+ mobilization was dependent on two events: release and influx. Both U73122 (1-[6-[[17-β-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione) [a phospholipase C (PLC) inhibitor] and genistein (a tyrosine kinase inhibitor) partially inhibited BK-stimulated rise in [Ca2+]i. When combined, both agents produced a further decrease, suggesting multiple pathways for PLC activation may be involved. The ability of Ni2+ to inhibit influx indicated the activation of a Ca2+ release-activated channel (CRAC). Ca2+ mobilization did not seem to be affected by cyclic nucleotides or protein kinase C. In summary, the TKPTS murine proximal tubule cell line expresses functional B2 receptors linked to Ca2+ mobilization that is dependent on phospholipase C and activation of CRAC.Keywords
This publication has 35 references indexed in Scilit:
- Identification and characterisation of GPR100 as a novel human G‐protein‐coupled bradykinin receptorBritish Journal of Pharmacology, 2003
- Bradykinin B2 Receptor Activates Extracellular Signal-Regulated Protein Kinase in mIMCD-3 Cells via Epidermal Growth Factor Receptor TransactivationThe Journal of pharmacology and experimental therapeutics, 2002
- Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculatureKidney International, 1999
- Uncoupling of bradykinin-induced phosphoinositide hydrolysis and Ca2+mobilization by phorbol ester in canine cultured tracheal epithelial cellsBritish Journal of Pharmacology, 1998
- Bradykinin Stimulates the Tyrosine Phosphorylation and Bradykinin B2 Receptor Association of Phospholipase Cγ1 in Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1998
- βγ Subunits of Pertussis Toxin-sensitive G Proteins Mediate A1 Adenosine Receptor Agonist-induced Activation of Phospholipase C in Collaboration with ThyrotropinPublished by Elsevier BV ,1997
- Analysis of competitive agonist-antagonist interactions by nonlinear regressionTrends in Pharmacological Sciences, 1995
- Probing for the bradykinin B2 receptor in rat kidney by anti-peptide and anti-ligand antibodies.Journal of Histochemistry & Cytochemistry, 1995
- Bradykinin AntagonistsAnnual Review of Pharmacology and Toxicology, 1991
- Phorbol myristate acetate-induced release of granule enzymes from human neutrophils: Inhibition by the calcium antagonist, 8-(N,N-diethylamino)-octyl 3,4,5-trimethoxybenzoate hydrochlorideBiochemical and Biophysical Research Communications, 1979